Defective SLC2A10 causes arterial tortuosity syndrome (ATS)

Stable Identifier
R-HSA-5619068
Type
Pathway
Species
Homo sapiens
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser
Four class III facilitative transporters can transport glucose; SLC2A6, 8, 10 and 12 (encoding GLUT6, 8, 10 and 12 respectively). SLC2A10 (located in the Type 2 diabetes-linked region of human chromosome 20q12-13.1) encodes GLUT10, a transporter with high affinity for glucose. GLUT10 is highly expressed in liver and pancreas but is present at lower levels in most tissues. Defects in SLC2A10 are the cause of arterial tortuosity syndrome (ATS), an autosomal recessive disorder of connective tissue characterised by tortuosity and elongation of major arteries, often resulting in death at a young age (Coucke et al. 2006, Callewaert et al. 2008).
Literature References
PubMed ID Title Journal Year
16550171 Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome

Callewaert, B, Coucke, PJ, Willems, PJ, Gardella, R, Wessels, MW, Mancini, GM, Barlati, S, Facchetti, F, De Backer, J, Loeys, B, Fox, JE, De Paepe, A, Dietz, HC, Forsyth, R, Colombi, M, Willaert, A, Kambouris, M, Zoppi, N

Nat Genet 2006
17935213 Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families

Willaert, A, Ramos-Arroyo, MA, Albrecht, B, Devriendt, K, Coucke, PJ, Hennekam, RC, Pyeritz, RE, Doco-Fenzy, M, Loeys, BL, Kerstjens-Frederikse, WS, Callewaert, BL, Nik-zainal, S, De Paepe, AM, Francannet, C, Gillessen-kaesbach, G, Booth, C, Krogmann, ON, Dekens, R, Barrow, M, Mauran, P, Wakeling, EL, De Backer, J

Hum. Mutat. 2008
Participants
Participates
Disease
Authored
Reviewed
Created
Cite Us!